American Red Cross

Cell & Gene Therapy Solutions is a nationwide leader in the provision of allogeneic and autologous collections for cell and gene therapy. Our products support a broad range of uses, from bench research to use in clinical trials and the manufacture of commercial therapies.

Our mission is to provide comprehensive solutions to clients by leveraging our physician, nursing, and technical expertise. These strengths, along with the power of the Red Cross brand enable us to deliver tailored life-saving products and services when and where patients need them. As a leading source of key raw materials for the cell and gene therapy industry and academic institutions, we provide patients an opportunity for improved quality of life.

Autologous Mononuclear Cell collections are performed at 62 Red Cross sites across the country and at multiple hospital locations. Our five full-service cellular therapy labs perform processing, freezing and storage of apheresis material. This, along with our ability to offer robust customization, allows us to both collect and process apheresis products according to our customers’ specifications and unique needs.